nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—TOP2B—hair follicle—skin cancer	0.0233	0.214	CbGeAlD
Dexrazoxane—TOP2B—nipple—skin cancer	0.0158	0.145	CbGeAlD
Dexrazoxane—TOP2A—nipple—skin cancer	0.0116	0.107	CbGeAlD
Dexrazoxane—TOP2A—Sorafenib—Vismodegib—skin cancer	0.0113	0.584	CbGdCrCtD
Dexrazoxane—TOP2B—connective tissue—skin cancer	0.0112	0.103	CbGeAlD
Dexrazoxane—TOP2B—mammalian vulva—skin cancer	0.00924	0.0849	CbGeAlD
Dexrazoxane—TOP2B—lymphoid tissue—skin cancer	0.0082	0.0754	CbGeAlD
Dexrazoxane—TOP2A—Paclitaxel—Docetaxel—skin cancer	0.00802	0.416	CbGdCrCtD
Dexrazoxane—TOP2B—female reproductive system—skin cancer	0.00791	0.0727	CbGeAlD
Dexrazoxane—TOP2A—mammalian vulva—skin cancer	0.00679	0.0624	CbGeAlD
Dexrazoxane—TOP2B—head—skin cancer	0.00661	0.0608	CbGeAlD
Dexrazoxane—TOP2B—lymph node—skin cancer	0.00463	0.0425	CbGeAlD
Dexrazoxane—TOP2A—lymph node—skin cancer	0.0034	0.0313	CbGeAlD
Dexrazoxane—Loss of consciousness—Imiquimod—skin cancer	0.00217	0.00249	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Temozolomide—skin cancer	0.00217	0.00248	CcSEcCtD
Dexrazoxane—Cough—Imiquimod—skin cancer	0.00215	0.00247	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00215	0.00247	CcSEcCtD
Dexrazoxane—Dysphagia—Temozolomide—skin cancer	0.00212	0.00243	CcSEcCtD
Dexrazoxane—Pneumonia—Dactinomycin—skin cancer	0.0021	0.00241	CcSEcCtD
Dexrazoxane—Myalgia—Imiquimod—skin cancer	0.0021	0.00241	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00209	0.00239	CcSEcCtD
Dexrazoxane—Discomfort—Imiquimod—skin cancer	0.00208	0.00238	CcSEcCtD
Dexrazoxane—Oesophagitis—Docetaxel—skin cancer	0.00206	0.00236	CcSEcCtD
Dexrazoxane—Dry mouth—Imiquimod—skin cancer	0.00205	0.00236	CcSEcCtD
Dexrazoxane—Decreased appetite—Vemurafenib—skin cancer	0.00205	0.00235	CcSEcCtD
Dexrazoxane—Stomatitis—Dactinomycin—skin cancer	0.00204	0.00234	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00204	0.00234	CcSEcCtD
Dexrazoxane—Fatigue—Vemurafenib—skin cancer	0.00204	0.00234	CcSEcCtD
Dexrazoxane—Haemoglobin—Bleomycin—skin cancer	0.00202	0.00232	CcSEcCtD
Dexrazoxane—Constipation—Vemurafenib—skin cancer	0.00202	0.00232	CcSEcCtD
Dexrazoxane—Pancytopenia—Temozolomide—skin cancer	0.00202	0.00231	CcSEcCtD
Dexrazoxane—Haemorrhage—Bleomycin—skin cancer	0.00201	0.00231	CcSEcCtD
Dexrazoxane—Infection—Imiquimod—skin cancer	0.002	0.00229	CcSEcCtD
Dexrazoxane—Neutropenia—Temozolomide—skin cancer	0.00198	0.00228	CcSEcCtD
Dexrazoxane—Shock—Imiquimod—skin cancer	0.00198	0.00227	CcSEcCtD
Dexrazoxane—Nervous system disorder—Imiquimod—skin cancer	0.00198	0.00227	CcSEcCtD
Dexrazoxane—Skin disorder—Imiquimod—skin cancer	0.00196	0.00224	CcSEcCtD
Dexrazoxane—Dysphagia—Fluorouracil—skin cancer	0.00196	0.00224	CcSEcCtD
Dexrazoxane—Agranulocytosis—Dactinomycin—skin cancer	0.00195	0.00224	CcSEcCtD
Dexrazoxane—Sepsis—Docetaxel—skin cancer	0.00195	0.00224	CcSEcCtD
Dexrazoxane—Weight decreased—Temozolomide—skin cancer	0.00192	0.0022	CcSEcCtD
Dexrazoxane—Anorexia—Imiquimod—skin cancer	0.00192	0.0022	CcSEcCtD
Dexrazoxane—Pneumonia—Temozolomide—skin cancer	0.0019	0.00218	CcSEcCtD
Dexrazoxane—Phlebitis—Docetaxel—skin cancer	0.0019	0.00217	CcSEcCtD
Dexrazoxane—Infestation NOS—Temozolomide—skin cancer	0.00189	0.00217	CcSEcCtD
Dexrazoxane—Infestation—Temozolomide—skin cancer	0.00189	0.00217	CcSEcCtD
Dexrazoxane—Depression—Temozolomide—skin cancer	0.00189	0.00216	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.00188	0.00215	CcSEcCtD
Dexrazoxane—Body temperature increased—Vemurafenib—skin cancer	0.00187	0.00214	CcSEcCtD
Dexrazoxane—Pancytopenia—Fluorouracil—skin cancer	0.00186	0.00213	CcSEcCtD
Dexrazoxane—Stomatitis—Temozolomide—skin cancer	0.00184	0.00212	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00183	0.0021	CcSEcCtD
Dexrazoxane—Insomnia—Imiquimod—skin cancer	0.00182	0.00209	CcSEcCtD
Dexrazoxane—Cardiac failure congestive—Docetaxel—skin cancer	0.0018	0.00207	CcSEcCtD
Dexrazoxane—Dyspnoea—Imiquimod—skin cancer	0.0018	0.00206	CcSEcCtD
Dexrazoxane—Somnolence—Imiquimod—skin cancer	0.00179	0.00205	CcSEcCtD
Dexrazoxane—Alopecia—Bleomycin—skin cancer	0.00178	0.00204	CcSEcCtD
Dexrazoxane—Pneumonia—Fluorouracil—skin cancer	0.00175	0.00201	CcSEcCtD
Dexrazoxane—Erythema—Bleomycin—skin cancer	0.00175	0.00201	CcSEcCtD
Dexrazoxane—Decreased appetite—Imiquimod—skin cancer	0.00175	0.00201	CcSEcCtD
Dexrazoxane—Infestation NOS—Fluorouracil—skin cancer	0.00174	0.002	CcSEcCtD
Dexrazoxane—Infestation—Fluorouracil—skin cancer	0.00174	0.002	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Imiquimod—skin cancer	0.00174	0.00199	CcSEcCtD
Dexrazoxane—Fatigue—Imiquimod—skin cancer	0.00174	0.00199	CcSEcCtD
Dexrazoxane—Pain—Imiquimod—skin cancer	0.00172	0.00198	CcSEcCtD
Dexrazoxane—Haemoglobin—Temozolomide—skin cancer	0.00171	0.00196	CcSEcCtD
Dexrazoxane—Stomatitis—Fluorouracil—skin cancer	0.0017	0.00195	CcSEcCtD
Dexrazoxane—Haemorrhage—Temozolomide—skin cancer	0.0017	0.00195	CcSEcCtD
Dexrazoxane—Asthenia—Vemurafenib—skin cancer	0.00169	0.00194	CcSEcCtD
Dexrazoxane—Oedema peripheral—Temozolomide—skin cancer	0.00167	0.00192	CcSEcCtD
Dexrazoxane—Pruritus—Vemurafenib—skin cancer	0.00167	0.00192	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Temozolomide—skin cancer	0.00167	0.00191	CcSEcCtD
Dexrazoxane—Alopecia—Dactinomycin—skin cancer	0.00166	0.0019	CcSEcCtD
Dexrazoxane—Feeling abnormal—Imiquimod—skin cancer	0.00166	0.0019	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Imiquimod—skin cancer	0.00165	0.00189	CcSEcCtD
Dexrazoxane—Hyponatraemia—Docetaxel—skin cancer	0.00164	0.00188	CcSEcCtD
Dexrazoxane—Erythema—Dactinomycin—skin cancer	0.00164	0.00188	CcSEcCtD
Dexrazoxane—Agranulocytosis—Fluorouracil—skin cancer	0.00163	0.00187	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Bleomycin—skin cancer	0.00163	0.00187	CcSEcCtD
Dexrazoxane—Anaemia—Bleomycin—skin cancer	0.00162	0.00186	CcSEcCtD
Dexrazoxane—Diarrhoea—Vemurafenib—skin cancer	0.00162	0.00185	CcSEcCtD
Dexrazoxane—Urticaria—Imiquimod—skin cancer	0.0016	0.00183	CcSEcCtD
Dexrazoxane—Body temperature increased—Imiquimod—skin cancer	0.00159	0.00183	CcSEcCtD
Dexrazoxane—Abdominal pain—Imiquimod—skin cancer	0.00159	0.00183	CcSEcCtD
Dexrazoxane—Malaise—Bleomycin—skin cancer	0.00158	0.00181	CcSEcCtD
Dexrazoxane—Cardiac disorder—Temozolomide—skin cancer	0.00158	0.00181	CcSEcCtD
Dexrazoxane—Haemoglobin—Fluorouracil—skin cancer	0.00157	0.0018	CcSEcCtD
Dexrazoxane—Leukopenia—Bleomycin—skin cancer	0.00157	0.0018	CcSEcCtD
Dexrazoxane—Haemorrhage—Fluorouracil—skin cancer	0.00157	0.0018	CcSEcCtD
Dexrazoxane—Dizziness—Vemurafenib—skin cancer	0.00156	0.00179	CcSEcCtD
Dexrazoxane—Angiopathy—Temozolomide—skin cancer	0.00154	0.00177	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Temozolomide—skin cancer	0.00153	0.00176	CcSEcCtD
Dexrazoxane—Cough—Bleomycin—skin cancer	0.00153	0.00175	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Dactinomycin—skin cancer	0.00152	0.00174	CcSEcCtD
Dexrazoxane—Anaemia—Dactinomycin—skin cancer	0.00151	0.00173	CcSEcCtD
Dexrazoxane—Vomiting—Vemurafenib—skin cancer	0.0015	0.00172	CcSEcCtD
Dexrazoxane—Alopecia—Temozolomide—skin cancer	0.0015	0.00172	CcSEcCtD
Dexrazoxane—Myalgia—Bleomycin—skin cancer	0.00149	0.00171	CcSEcCtD
Dexrazoxane—Mental disorder—Temozolomide—skin cancer	0.00149	0.00171	CcSEcCtD
Dexrazoxane—Headache—Vemurafenib—skin cancer	0.00148	0.0017	CcSEcCtD
Dexrazoxane—Malnutrition—Temozolomide—skin cancer	0.00148	0.0017	CcSEcCtD
Dexrazoxane—Erythema—Temozolomide—skin cancer	0.00148	0.0017	CcSEcCtD
Dexrazoxane—Breast disorder—Docetaxel—skin cancer	0.00148	0.00169	CcSEcCtD
Dexrazoxane—Discomfort—Bleomycin—skin cancer	0.00147	0.00169	CcSEcCtD
Dexrazoxane—Malaise—Dactinomycin—skin cancer	0.00147	0.00169	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00147	0.00169	CcSEcCtD
Dexrazoxane—Leukopenia—Dactinomycin—skin cancer	0.00146	0.00168	CcSEcCtD
Dexrazoxane—Asthenia—Imiquimod—skin cancer	0.00145	0.00166	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00144	0.00165	CcSEcCtD
Dexrazoxane—Pruritus—Imiquimod—skin cancer	0.00142	0.00163	CcSEcCtD
Dexrazoxane—Infection—Bleomycin—skin cancer	0.00142	0.00163	CcSEcCtD
Dexrazoxane—Dysphagia—Docetaxel—skin cancer	0.00141	0.00162	CcSEcCtD
Dexrazoxane—Nausea—Vemurafenib—skin cancer	0.0014	0.00161	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Bleomycin—skin cancer	0.0014	0.00161	CcSEcCtD
Dexrazoxane—Myalgia—Dactinomycin—skin cancer	0.00139	0.0016	CcSEcCtD
Dexrazoxane—Tremor—Temozolomide—skin cancer	0.00139	0.00159	CcSEcCtD
Dexrazoxane—Alopecia—Fluorouracil—skin cancer	0.00138	0.00159	CcSEcCtD
Dexrazoxane—Diarrhoea—Imiquimod—skin cancer	0.00138	0.00158	CcSEcCtD
Dexrazoxane—Discomfort—Dactinomycin—skin cancer	0.00138	0.00158	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Temozolomide—skin cancer	0.00137	0.00157	CcSEcCtD
Dexrazoxane—Anaemia—Temozolomide—skin cancer	0.00137	0.00157	CcSEcCtD
Dexrazoxane—Anorexia—Bleomycin—skin cancer	0.00136	0.00156	CcSEcCtD
Dexrazoxane—Erythema—Fluorouracil—skin cancer	0.00136	0.00156	CcSEcCtD
Dexrazoxane—Pancytopenia—Docetaxel—skin cancer	0.00134	0.00154	CcSEcCtD
Dexrazoxane—Malaise—Temozolomide—skin cancer	0.00133	0.00153	CcSEcCtD
Dexrazoxane—Dizziness—Imiquimod—skin cancer	0.00133	0.00153	CcSEcCtD
Dexrazoxane—Infection—Dactinomycin—skin cancer	0.00133	0.00152	CcSEcCtD
Dexrazoxane—Leukopenia—Temozolomide—skin cancer	0.00132	0.00152	CcSEcCtD
Dexrazoxane—Neutropenia—Docetaxel—skin cancer	0.00132	0.00151	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Dactinomycin—skin cancer	0.00131	0.0015	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Bleomycin—skin cancer	0.0013	0.00149	CcSEcCtD
Dexrazoxane—Cough—Temozolomide—skin cancer	0.00129	0.00148	CcSEcCtD
Dexrazoxane—Vomiting—Imiquimod—skin cancer	0.00128	0.00147	CcSEcCtD
Dexrazoxane—Weight decreased—Docetaxel—skin cancer	0.00128	0.00146	CcSEcCtD
Dexrazoxane—Dyspnoea—Bleomycin—skin cancer	0.00128	0.00146	CcSEcCtD
Dexrazoxane—Anorexia—Dactinomycin—skin cancer	0.00127	0.00146	CcSEcCtD
Dexrazoxane—Pneumonia—Docetaxel—skin cancer	0.00127	0.00145	CcSEcCtD
Dexrazoxane—Headache—Imiquimod—skin cancer	0.00126	0.00145	CcSEcCtD
Dexrazoxane—Anaemia—Fluorouracil—skin cancer	0.00126	0.00144	CcSEcCtD
Dexrazoxane—Myalgia—Temozolomide—skin cancer	0.00126	0.00144	CcSEcCtD
Dexrazoxane—Infestation—Docetaxel—skin cancer	0.00126	0.00144	CcSEcCtD
Dexrazoxane—Infestation NOS—Docetaxel—skin cancer	0.00126	0.00144	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00125	0.00143	CcSEcCtD
Dexrazoxane—Discomfort—Temozolomide—skin cancer	0.00124	0.00143	CcSEcCtD
Dexrazoxane—Decreased appetite—Bleomycin—skin cancer	0.00124	0.00143	CcSEcCtD
Dexrazoxane—Dry mouth—Temozolomide—skin cancer	0.00123	0.00141	CcSEcCtD
Dexrazoxane—Stomatitis—Docetaxel—skin cancer	0.00123	0.00141	CcSEcCtD
Dexrazoxane—Pain—Bleomycin—skin cancer	0.00122	0.0014	CcSEcCtD
Dexrazoxane—Leukopenia—Fluorouracil—skin cancer	0.00122	0.0014	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00122	0.00139	CcSEcCtD
Dexrazoxane—Infection—Temozolomide—skin cancer	0.0012	0.00138	CcSEcCtD
Dexrazoxane—Nausea—Imiquimod—skin cancer	0.0012	0.00137	CcSEcCtD
Dexrazoxane—Nervous system disorder—Temozolomide—skin cancer	0.00118	0.00136	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Temozolomide—skin cancer	0.00118	0.00136	CcSEcCtD
Dexrazoxane—Feeling abnormal—Bleomycin—skin cancer	0.00118	0.00135	CcSEcCtD
Dexrazoxane—Agranulocytosis—Docetaxel—skin cancer	0.00117	0.00135	CcSEcCtD
Dexrazoxane—Skin disorder—Temozolomide—skin cancer	0.00117	0.00134	CcSEcCtD
Dexrazoxane—Myalgia—Fluorouracil—skin cancer	0.00116	0.00133	CcSEcCtD
Dexrazoxane—Decreased appetite—Dactinomycin—skin cancer	0.00116	0.00133	CcSEcCtD
Dexrazoxane—Fatigue—Dactinomycin—skin cancer	0.00115	0.00132	CcSEcCtD
Dexrazoxane—Anorexia—Temozolomide—skin cancer	0.00115	0.00132	CcSEcCtD
Dexrazoxane—Discomfort—Fluorouracil—skin cancer	0.00115	0.00131	CcSEcCtD
Dexrazoxane—Pain—Dactinomycin—skin cancer	0.00114	0.00131	CcSEcCtD
Dexrazoxane—Urticaria—Bleomycin—skin cancer	0.00114	0.0013	CcSEcCtD
Dexrazoxane—Haemoglobin—Docetaxel—skin cancer	0.00114	0.0013	CcSEcCtD
Dexrazoxane—Body temperature increased—Bleomycin—skin cancer	0.00113	0.0013	CcSEcCtD
Dexrazoxane—Haemorrhage—Docetaxel—skin cancer	0.00113	0.0013	CcSEcCtD
Dexrazoxane—Oedema peripheral—Docetaxel—skin cancer	0.00111	0.00128	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Docetaxel—skin cancer	0.00111	0.00127	CcSEcCtD
Dexrazoxane—Infection—Fluorouracil—skin cancer	0.0011	0.00127	CcSEcCtD
Dexrazoxane—Feeling abnormal—Dactinomycin—skin cancer	0.0011	0.00126	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Temozolomide—skin cancer	0.0011	0.00126	CcSEcCtD
Dexrazoxane—Insomnia—Temozolomide—skin cancer	0.00109	0.00125	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Dactinomycin—skin cancer	0.00109	0.00125	CcSEcCtD
Dexrazoxane—Nervous system disorder—Fluorouracil—skin cancer	0.00109	0.00125	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Fluorouracil—skin cancer	0.00109	0.00125	CcSEcCtD
Dexrazoxane—Dyspnoea—Temozolomide—skin cancer	0.00108	0.00123	CcSEcCtD
Dexrazoxane—Somnolence—Temozolomide—skin cancer	0.00107	0.00123	CcSEcCtD
Dexrazoxane—Anorexia—Fluorouracil—skin cancer	0.00106	0.00122	CcSEcCtD
Dexrazoxane—Abdominal pain—Dactinomycin—skin cancer	0.00105	0.00121	CcSEcCtD
Dexrazoxane—Body temperature increased—Dactinomycin—skin cancer	0.00105	0.00121	CcSEcCtD
Dexrazoxane—Decreased appetite—Temozolomide—skin cancer	0.00105	0.0012	CcSEcCtD
Dexrazoxane—Cardiac disorder—Docetaxel—skin cancer	0.00105	0.0012	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Temozolomide—skin cancer	0.00104	0.0012	CcSEcCtD
Dexrazoxane—Fatigue—Temozolomide—skin cancer	0.00104	0.00119	CcSEcCtD
Dexrazoxane—Pain—Temozolomide—skin cancer	0.00103	0.00118	CcSEcCtD
Dexrazoxane—Constipation—Temozolomide—skin cancer	0.00103	0.00118	CcSEcCtD
Dexrazoxane—Asthenia—Bleomycin—skin cancer	0.00103	0.00118	CcSEcCtD
Dexrazoxane—Angiopathy—Docetaxel—skin cancer	0.00102	0.00118	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Docetaxel—skin cancer	0.00102	0.00117	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00101	0.00116	CcSEcCtD
Dexrazoxane—Pruritus—Bleomycin—skin cancer	0.00101	0.00116	CcSEcCtD
Dexrazoxane—Insomnia—Fluorouracil—skin cancer	0.00101	0.00115	CcSEcCtD
Dexrazoxane—Alopecia—Docetaxel—skin cancer	0.000998	0.00114	CcSEcCtD
Dexrazoxane—Feeling abnormal—Temozolomide—skin cancer	0.000995	0.00114	CcSEcCtD
Dexrazoxane—Dyspnoea—Fluorouracil—skin cancer	0.000991	0.00114	CcSEcCtD
Dexrazoxane—Mental disorder—Docetaxel—skin cancer	0.00099	0.00114	CcSEcCtD
Dexrazoxane—Somnolence—Fluorouracil—skin cancer	0.000989	0.00113	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Temozolomide—skin cancer	0.000987	0.00113	CcSEcCtD
Dexrazoxane—Malnutrition—Docetaxel—skin cancer	0.000983	0.00113	CcSEcCtD
Dexrazoxane—Erythema—Docetaxel—skin cancer	0.000983	0.00113	CcSEcCtD
Dexrazoxane—Decreased appetite—Fluorouracil—skin cancer	0.000967	0.00111	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00096	0.0011	CcSEcCtD
Dexrazoxane—Urticaria—Temozolomide—skin cancer	0.000959	0.0011	CcSEcCtD
Dexrazoxane—Asthenia—Dactinomycin—skin cancer	0.000957	0.0011	CcSEcCtD
Dexrazoxane—Abdominal pain—Temozolomide—skin cancer	0.000954	0.00109	CcSEcCtD
Dexrazoxane—Body temperature increased—Temozolomide—skin cancer	0.000954	0.00109	CcSEcCtD
Dexrazoxane—Pain—Fluorouracil—skin cancer	0.000951	0.00109	CcSEcCtD
Dexrazoxane—Feeling abnormal—Fluorouracil—skin cancer	0.000916	0.00105	CcSEcCtD
Dexrazoxane—Diarrhoea—Dactinomycin—skin cancer	0.000913	0.00105	CcSEcCtD
Dexrazoxane—Vomiting—Bleomycin—skin cancer	0.00091	0.00104	CcSEcCtD
Dexrazoxane—Anaemia—Docetaxel—skin cancer	0.000909	0.00104	CcSEcCtD
Dexrazoxane—Urticaria—Fluorouracil—skin cancer	0.000883	0.00101	CcSEcCtD
Dexrazoxane—Syncope—Docetaxel—skin cancer	0.000882	0.00101	CcSEcCtD
Dexrazoxane—Leukopenia—Docetaxel—skin cancer	0.00088	0.00101	CcSEcCtD
Dexrazoxane—Body temperature increased—Fluorouracil—skin cancer	0.000879	0.00101	CcSEcCtD
Dexrazoxane—Asthenia—Temozolomide—skin cancer	0.000866	0.000993	CcSEcCtD
Dexrazoxane—Loss of consciousness—Docetaxel—skin cancer	0.000864	0.000991	CcSEcCtD
Dexrazoxane—Cough—Docetaxel—skin cancer	0.000858	0.000984	CcSEcCtD
Dexrazoxane—Pruritus—Temozolomide—skin cancer	0.000854	0.000979	CcSEcCtD
Dexrazoxane—Nausea—Bleomycin—skin cancer	0.00085	0.000975	CcSEcCtD
Dexrazoxane—Vomiting—Dactinomycin—skin cancer	0.000848	0.000973	CcSEcCtD
Dexrazoxane—Myalgia—Docetaxel—skin cancer	0.000837	0.00096	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000832	0.000954	CcSEcCtD
Dexrazoxane—Diarrhoea—Temozolomide—skin cancer	0.000826	0.000947	CcSEcCtD
Dexrazoxane—Dry mouth—Docetaxel—skin cancer	0.000819	0.000939	CcSEcCtD
Dexrazoxane—Dizziness—Temozolomide—skin cancer	0.000798	0.000915	CcSEcCtD
Dexrazoxane—Infection—Docetaxel—skin cancer	0.000797	0.000914	CcSEcCtD
Dexrazoxane—Nausea—Dactinomycin—skin cancer	0.000793	0.000909	CcSEcCtD
Dexrazoxane—Shock—Docetaxel—skin cancer	0.00079	0.000906	CcSEcCtD
Dexrazoxane—Nervous system disorder—Docetaxel—skin cancer	0.000787	0.000903	CcSEcCtD
Dexrazoxane—Pruritus—Fluorouracil—skin cancer	0.000787	0.000902	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Docetaxel—skin cancer	0.000786	0.000901	CcSEcCtD
Dexrazoxane—Skin disorder—Docetaxel—skin cancer	0.00078	0.000894	CcSEcCtD
Dexrazoxane—Vomiting—Temozolomide—skin cancer	0.000767	0.00088	CcSEcCtD
Dexrazoxane—Anorexia—Docetaxel—skin cancer	0.000765	0.000877	CcSEcCtD
Dexrazoxane—Diarrhoea—Fluorouracil—skin cancer	0.000761	0.000873	CcSEcCtD
Dexrazoxane—Headache—Temozolomide—skin cancer	0.000756	0.000867	CcSEcCtD
Dexrazoxane—Dizziness—Fluorouracil—skin cancer	0.000735	0.000843	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000731	0.000839	CcSEcCtD
Dexrazoxane—Insomnia—Docetaxel—skin cancer	0.000726	0.000833	CcSEcCtD
Dexrazoxane—Nausea—Temozolomide—skin cancer	0.000717	0.000822	CcSEcCtD
Dexrazoxane—Dyspnoea—Docetaxel—skin cancer	0.000716	0.000821	CcSEcCtD
Dexrazoxane—Somnolence—Docetaxel—skin cancer	0.000714	0.000818	CcSEcCtD
Dexrazoxane—Vomiting—Fluorouracil—skin cancer	0.000707	0.000811	CcSEcCtD
Dexrazoxane—Decreased appetite—Docetaxel—skin cancer	0.000698	0.0008	CcSEcCtD
Dexrazoxane—Headache—Fluorouracil—skin cancer	0.000697	0.000799	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Docetaxel—skin cancer	0.000693	0.000795	CcSEcCtD
Dexrazoxane—Fatigue—Docetaxel—skin cancer	0.000692	0.000794	CcSEcCtD
Dexrazoxane—Pain—Docetaxel—skin cancer	0.000686	0.000787	CcSEcCtD
Dexrazoxane—Constipation—Docetaxel—skin cancer	0.000686	0.000787	CcSEcCtD
Dexrazoxane—Feeling abnormal—Docetaxel—skin cancer	0.000661	0.000759	CcSEcCtD
Dexrazoxane—Nausea—Fluorouracil—skin cancer	0.000661	0.000758	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Docetaxel—skin cancer	0.000656	0.000753	CcSEcCtD
Dexrazoxane—Body temperature increased—Docetaxel—skin cancer	0.000634	0.000728	CcSEcCtD
Dexrazoxane—Abdominal pain—Docetaxel—skin cancer	0.000634	0.000728	CcSEcCtD
Dexrazoxane—Asthenia—Docetaxel—skin cancer	0.000576	0.00066	CcSEcCtD
Dexrazoxane—Pruritus—Docetaxel—skin cancer	0.000568	0.000651	CcSEcCtD
Dexrazoxane—Diarrhoea—Docetaxel—skin cancer	0.000549	0.00063	CcSEcCtD
Dexrazoxane—Dizziness—Docetaxel—skin cancer	0.000531	0.000609	CcSEcCtD
Dexrazoxane—Vomiting—Docetaxel—skin cancer	0.00051	0.000585	CcSEcCtD
Dexrazoxane—Headache—Docetaxel—skin cancer	0.000503	0.000577	CcSEcCtD
Dexrazoxane—Nausea—Docetaxel—skin cancer	0.000477	0.000547	CcSEcCtD
